Apimeds Pharmaceuticals Us (APUS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Apimeds Pharmaceuticals US, Inc.  (NYSE: APUS)

Apimeds Pharmaceuticals Us Profitability Comparisons

Select each Category to receive further Information




APUS Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 68.81 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) - 69.19 % 55.83 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 54.59 % 50.06 % 26.63 %
EBITDA Margin (Q2 MRQ) - 24.91 % 21.71 % 22.29 %
EBITDA Margin (Q2 TTM) - 28.73 % 23.62 % 20.86 %
EBITDA Margin 5 Yr. Avg. - 22.66 % 20.31 % 11.84 %
Operating Margin (Q2 MRQ) - 17.3 % 16.59 % 16.03 %
Operating Margin (Q2 TTM) - 20.31 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 18.61 % 12 % 8.21 %
Pre-Tax Profit Margin (Q2 MRQ) - 13.66 % 10.94 % 13.95 %
Pre-Tax Profit Margin (Q2 TTM) - 16.69 % 12.85 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 21.15 % 12.22 % 8.29 %
Net Margin (Q2 MRQ) - 10.08 % 8.14 % 11.42 %
Net Margin (Q2 TTM) - 13.08 % 9.97 % 10.76 %
Net Margin 5 Yr. Avg. - 15.99 % 7.99 % 6.33 %



Business Segment Profit Margin
 
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - 14.7 % 13.26 % 9.55 %
Free Cash Flow Margin (Q2 TTM) - 17.13 % 13.96 % 9.24 %
Free Cash Flow Margin 5 Yr. Avg. - 22.22 % 13.86 % 9.05 %
Net Cash Flow Margin (Q2 MRQ) - -1.53 % 1.46 % 2.2 %
Net Cash Flow Margin (Q2 TTM) - -0.76 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 0.26 % 1.42 % 1.4 %
Effective Tax Rate (Q2 MRQ) - 25.97 % 25.4 % 18.77 %
Effective Tax Rate (Q2 TTM)